⌘K

Login Start Free

Home/Filings/3/0001493152-22-022518

3//SEC Filing

Leonite Capital LLC 3

Accession 0001493152-22-022518

CIK 0001841330other

View on SEC.gov Company Profile

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 6:12 AM ET

Size

5.5 KB

Accession

0001493152-22-022518

Insider Transaction Report

Form 3

Period: 2022-08-09

Pasithea Therapeutics Corp.KTTA

10% OwnerOther

Holdings

Common Stock
(indirect: See footnote)
1,034,702

Footnotes (1)

[F1]The shares are held by Leonite Capital LLC, of which Avi Geller serves as Chief Investment Officer.

Documents

1 file

3
ownership.xmlPrimary

Issuer

Pasithea Therapeutics Corp.

CIK 0001841330

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001824520

Filing Metadata

Form type: 3
Filed: Aug 14, 8:00 PM ET
Accepted: Aug 15, 6:12 AM ET
Size: 5.5 KB

View on SEC.gov